Entourage Health Corp. (
TSX-V:ENTG)
(
OTCQX:ETRGF) (
FSE:4WE)
(“
Entourage” or the “
Company”), a
Canadian producer and distributor of award-winning cannabis
products, is pleased to announce its medical subsidiary Starseed
Medicinal (“
Starseed”) has added four new union
groups to its full-service, proprietary medical cannabis program,
in partnership with leading benefits provider Union Benefits – the
administrator of union group benefits to over 12,000 members.
The medical cannabis plan, which goes into
effect September 1, 2022, provides eligible union members and their
dependents access to practitioners specializing in prescribing
medical cannabis as an insured benefit. Additionally, Starseed is a
unique platform with no co-pay or out-of-pocket insurance costs and
is currently recognized as one of the only medical cannabis
programs in the world to offer access to direct billing.
“We congratulate and proudly welcome our four
newest member unions and their locals to our full-service Starseed
medical platform. Together, we are removing the barriers to access
medical cannabis as an alternative therapy for members and benefits
provider Union Benefits, looking to responsibly educate and provide
treatment options to patients for a myriad of indications,” said
George Scorsis, CEO and Executive Chair, Entourage. “Our simplified
and personalized treatment plans are curated alongside our
award-winning healthcare experts who carefully ensure patients have
access to a portfolio of over 45 trusted medical cannabis products
including, soft-gel capsules, oils, soft-chews, patches, compounds
(balms), vapes, and dried flower. As a result of these widely
accepted therapeutic alternatives, coupled with a seamless
reimbursement process, we now have over 10 union groups, five
insurance providers, and 24 clinics signed to our Starseed
platform.”
“With this partnership we are providing our
members with access to the most innovative medical cannabis
products, treatments plans and trusted practitioners in the
industry, representing a progressive step forward in our evolving
service model for over 12,000 members and their dependents,” said
Rob Andrews, CEO and President, Union Benefits. “Our goal as a
third party administrator is to ensure our union families are
provided with access to affordable, quality-driven benefit options
to meet their health and wellness journeys. Removing barriers and
ease of payment is an important factor for expanding coverage to
new therapies and we’re proud to be offering this to our
members.”
All eligible affiliate members can now
immediately access Starseed’s medical cannabis program by
registering as patients. The Starseed program is built around a
system that brings together clinical practitioners who specialize
in chronic pain management, opioid cessation, insomnia and mental
health therapies. Its medical marketplace is built around a
revolutionary Canadian virtual pharmacy system that takes online
orders and has the ability to intuitively complete the claims
management process seamlessly with insurance carriers. More
recently, Starseed expanded access to same-day delivery with
Pineapple Express, increased service offerings by partnering with
HelloMD’s virtual telehealth network, and now provides tailored
patient treatment plans, plus innovative new products hosted on a
virtual education platform.
Visit Entourage’s website here to access the
latest Company updates.
About Entourage Health
Corp.
Entourage Health Corp. is the publicly traded
parent Company of Entourage Brands Corp. (formerly WeedMD RX Inc.)
and CannTx Life Sciences Inc., licence holders producing and
distributing cannabis products for both the medical and adult-use
markets. The Company owns and operates a state-of-the-art hybrid
greenhouse and processing facility located on 158-acres in
Strathroy, ON; a fully licensed 26,000 sq. ft. Aylmer, ON
processing facility, specializing in cannabis extraction; and a
micropropagation, tissue culture and genetics centre-of-excellence
in Guelph, Ontario. With its Starseed Medicinal medical-centric
brand, Entourage has expanded its multi-channeled distribution
strategy. Starseed’s industry-first, exclusive partnership with
LiUNA, the largest construction union in Canada, along with
employers and over 10 union groups complements Entourage’s direct
sales to medical patients. Entourage’s elite adult-use product
portfolio includes Color Cannabis, Saturday Cannabis and Royal City
Cannabis Co.– sold across eight provincial distribution agencies.
The Company also maintains strategic relationships in the seniors’
market and supply agreements with Shoppers Drug Mart. It is the
exclusive Canadian producer and distributor of award-winning
U.S.-based wellness brand Mary’s Medicinals sold in both medical
and adult-use channels. Under a collaboration with The Boston Beer
Company subsidiary, Entourage is also the exclusive distributor of
cannabis-infused beverages ‘TeaPot’ in Canada, which launched in
summer 2022, starting in select provinces.
For more information, please visit us at
www.entouragehealthcorp.com
Follow Entourage and its brands on LinkedIn
Twitter: Entourage, Color Cannabis, Saturday
Cannabis, Starseed & Royal City Cannabis Co.
Instagram: Entourage, Color Cannabis, Saturday
Cannabis, Starseed & Royal City Cannabis Co.
For further information, investor or
media inquiries, please contact:
Marianella delaBarreraSVP, Communications &
Corporate
Affairs416-897-6644marianella@entouragecorp.com investor@entouragecorp.com media@entouragecorp.com
Forward Looking Information
This press release contains "forward-looking information" within
the meaning of applicable Canadian securities legislation which are
based upon Entourage's current internal expectations, estimates,
projections, assumptions and beliefs and views of future events.
Forward-looking information can be identified by the use of
forward-looking terminology such as "expect", "likely", "may",
"will", "should", "intend", "anticipate", "potential", "proposed",
"estimate" and other similar words, including negative and
grammatical variations thereof, or statements that certain events
or conditions "may", "would" or "will" happen, or by discussions of
strategy.
The forward-looking information in this news
release is based upon the expectations, estimates, projections,
assumptions and views of future events which management believes to
be reasonable in the circumstances. Forward-looking information
includes estimates, plans, expectations, opinions, forecasts,
projections, targets, guidance or other statements that are not
statements of fact. Forward-looking information necessarily involve
known and unknown risks, including, without limitation, risks
associated with general economic conditions; adverse industry
events; loss of markets; future legislative and regulatory
developments; inability to access sufficient capital from internal
and external sources, and/or inability to access sufficient capital
on favourable terms; the cannabis industry
in Canada generally; the ability of Entourage to
implement its business strategies; the COVID-19 pandemic;
competition; crop failure; and other risks.
Any forward-looking information speaks only as
of the date on which it is made, and, except as required by law,
Entourage does not undertake any obligation to update or revise any
forward-looking information, whether as a result of new
information, future events or otherwise. New factors emerge from
time to time, and it is not possible for Entourage to predict all
such factors. When considering this forward-looking information,
readers should keep in mind the risk factors and other cautionary
statements in Entourage’s disclosure documents filed with the
applicable Canadian securities regulatory authorities on SEDAR at
www.sedar.com. The risk factors and other factors noted in the
disclosure documents could cause actual events or results to differ
materially from those described in any forward-looking
information.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Entourage Health (TSXV:ENTG)
Historical Stock Chart
From Apr 2023 to Apr 2024